Turn Therapeutics Inc. TTRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 1.61M | 974.50K | -- | -- | -- |
| Gross Profit | -1.61M | -974.50K | -- | -- | -- |
| SG&A Expenses | 6.20M | 6.35M | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.59M | 7.69M | -- | -- | -- |
| Operating Income | -8.59M | -7.69M | -- | -- | -- |
| Income Before Tax | -8.45M | -3.84M | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.45 | -3.84 | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.45M | -3.84M | -- | -- | -- |
| EBIT | -8.59M | -7.69M | -- | -- | -- |
| EBITDA | -8.54M | -7.64M | -- | -- | -- |
| EPS Basic | -0.29 | -0.14 | -- | -- | -- |
| Normalized Basic EPS | -0.18 | -0.09 | -- | -- | -- |
| EPS Diluted | -0.29 | -0.14 | -- | -- | -- |
| Normalized Diluted EPS | -0.18 | -0.09 | -- | -- | -- |
| Average Basic Shares Outstanding | 115.67M | 113.37M | -- | -- | -- |
| Average Diluted Shares Outstanding | 115.67M | 113.37M | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |